EDSA
Price
$1.73
Change
-$0.06 (-3.35%)
Updated
Nov 13 closing price
Capitalization
12.55M
Intraday BUY SELL Signals
ELAB
Price
$5.51
Change
-$0.15 (-2.65%)
Updated
Nov 13 closing price
Capitalization
4.09M
Intraday BUY SELL Signals
Interact to see
Advertisement

EDSA vs ELAB

Header iconEDSA vs ELAB Comparison
Open Charts EDSA vs ELABBanner chart's image
Edesa Biotech
Price$1.73
Change-$0.06 (-3.35%)
Volume$60.54K
Capitalization12.55M
PMGC Holdings
Price$5.51
Change-$0.15 (-2.65%)
Volume$31.07K
Capitalization4.09M
EDSA vs ELAB Comparison Chart in %
EDSA
Daily Signal:
Gain/Loss:
ELAB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
EDSA vs. ELAB commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDSA is a StrongBuy and ELAB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (EDSA: $1.73 vs. ELAB: $5.51)
Brand notoriety: EDSA and ELAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDSA: 14% vs. ELAB: 5%
Market capitalization -- EDSA: $12.55M vs. ELAB: $4.09M
EDSA [@Biotechnology] is valued at $12.55M. ELAB’s [@Biotechnology] market capitalization is $4.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDSA’s FA Score shows that 0 FA rating(s) are green whileELAB’s FA Score has 1 green FA rating(s).

  • EDSA’s FA Score: 0 green, 5 red.
  • ELAB’s FA Score: 1 green, 4 red.
According to our system of comparison, ELAB is a better buy in the long-term than EDSA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDSA’s TA Score shows that 5 TA indicator(s) are bullish while ELAB’s TA Score has 3 bullish TA indicator(s).

  • EDSA’s TA Score: 5 bullish, 5 bearish.
  • ELAB’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, EDSA is a better buy in the short-term than ELAB.

Price Growth

EDSA (@Biotechnology) experienced а +1.76% price change this week, while ELAB (@Biotechnology) price change was +1.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.64%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +66.73%.

Industries' Descriptions

@Biotechnology (+3.64% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EDSA($12.6M) has a higher market cap than ELAB($4.09M). EDSA YTD gains are higher at: 2.976 vs. ELAB (-90.179). ELAB has higher annual earnings (EBITDA): -4.37M vs. EDSA (-5.73M). EDSA has more cash in the bank: 12.4M vs. ELAB (6.31M). EDSA has less debt than ELAB: EDSA (0) vs ELAB (103K). EDSA (0) and ELAB (0) have equivalent revenues.
EDSAELABEDSA / ELAB
Capitalization12.6M4.09M308%
EBITDA-5.73M-4.37M131%
Gain YTD2.976-90.179-3%
P/E RatioN/A0.05-
Revenue00-
Total Cash12.4M6.31M197%
Total Debt0103K-
FUNDAMENTALS RATINGS
EDSA: Fundamental Ratings
EDSA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDSAELAB
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EDSA
Daily Signal:
Gain/Loss:
ELAB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SOLV75.221.39
+1.88%
Solventum Corp
OPTT0.44-0.01
-1.71%
Ocean Power Technologies
CSTM15.65-0.41
-2.55%
Constellium SE
CBLL12.49-0.36
-2.80%
CERIBELL INC
MYSZ1.11-0.04
-3.48%
My Size

EDSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, EDSA has been loosely correlated with DOMH. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EDSA jumps, then DOMH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDSA
1D Price
Change %
EDSA100%
-3.35%
DOMH - EDSA
37%
Loosely correlated
-10.83%
MBRX - EDSA
34%
Loosely correlated
-6.91%
TAOX - EDSA
33%
Poorly correlated
-13.28%
ORMP - EDSA
32%
Poorly correlated
-2.83%
RNAZ - EDSA
31%
Poorly correlated
-4.32%
More

ELAB and

Correlation & Price change

A.I.dvisor tells us that ELAB and LXRX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAB and LXRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-2.65%
LXRX - ELAB
25%
Poorly correlated
-6.49%
MTNB - ELAB
25%
Poorly correlated
-4.72%
EDSA - ELAB
24%
Poorly correlated
-3.35%
TGTX - ELAB
21%
Poorly correlated
-0.16%
TBPH - ELAB
21%
Poorly correlated
+0.96%
More